Quick Answer
ASPEN AEROGELS INC reported Total Revenue of $271.10 million for the year ending 2025.
- ASPEN AEROGELS INC showed a decrease of -40.1% in Total Revenue from 2024 to 2025.
- This data is from ASPEN AEROGELS INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $23.00 million | Q2 2017: $25.07 million | Q3 2017: $27.20 million | Q4 2017: $36.36 million | Q1 2018: $23.07 million | Q2 2018: $21.67 million | Q3 2018: $23.94 million | Q4 2018: $35.68 million | Q1 2019: $27.91 million | Q2 2019: $29.53 million | Q3 2019: $35.43 million | Q4 2019: $46.51 million | Q1 2020: $28.42 million | Q2 2020: $24.64 million | Q3 2020: $24.20 million | Q4 2020: $23.02 million | Q1 2021: $28.10 million | Q2 2021: $31.67 million | Q3 2021: $30.38 million | Q1 2022: $38.41 million | Q2 2022: $45.64 million | Q3 2022: $36.71 million | Q1 2023: $45.59 million | Q2 2023: $48.16 million | Q3 2023: $60.76 million | Q1 2024: $94.50 million | Q2 2024: $117.77 million | Q3 2024: $117.34 million | Q1 2025: $78.72 million | Q2 2025: $78.02 million | Q3 2025: $73.02 million.
- Over the full 10 years of available data (2016 to 2025), ASPEN AEROGELS INC's Total Revenue has grown by 130.3%.
- Historical annual values: Fiscal year 2025: $271.10 million | Fiscal year 2024: $452.70 million | Fiscal year 2023: $238.72 million | Fiscal year 2022: $180.36 million | Fiscal year 2021: $121.62 million | Fiscal year 2020: $100.27 million | Fiscal year 2019: $139.38 million | Fiscal year 2018: $104.36 million | Fiscal year 2017: $111.63 million | Fiscal year 2016: $117.74 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: